Ledger.Open graph →
SEC Form D · filed August 10, 2023

RevOpsis Therapeutics, Inc

Offering
$7.9M
Sold
$7.9M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SPRINGFIELD, IL
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (3)

Ramanath Bhandari · Springfield, ILExec · DirectorRam Palanki · Springfield, ILDirectorRam Palanki · Springfield, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗